Previous Article | Next Article 
Infection and Immunity, July 1999, p. 3610-3618, Vol. 67, No. 7
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Resistance of Virulent Mycobacterium
avium to Gamma Interferon-Mediated Antimicrobial Activity Suggests
Additional Signals for Induction of Mycobacteriostasis
Manuela
Flórido,1
Ana Sofia
Gonçalves,1
Regina A.
Silva,1
Stefan
Ehlers,2
Andrea M.
Cooper,3 and
Rui
Appelberg1,*
Laboratory of Microbiology and Immunology of
Infection, Institute for Molecular and Cell Biology, University of
Porto, Porto, Portugal1; Borstel
Research Center, Borstel, Germany2; and
Department of Microbiology, Colorado State University, Fort
Collins, Colorado3
Received 21 December 1998/Returned for modification 16 March
1999/Accepted 26 March 1999
 |
ABSTRACT |
The cytokine gamma interferon (IFN-
) plays a major role in the
control of Mycobacterium avium infections. We assessed
whether the progressive growth of virulent strains of M. avium was associated with alterations in the production of this
cytokine as evaluated by reverse transcription-PCR and detection of
immunoreactive cytokine in the serum and in spleen homogenates. We
found that IFN-
was induced during infection by a virulent strain of
M. avium to similar or even higher extents than the levels
found during infections by a less virulent strain whose growth was
controlled. IFN-
produced during infection by both mycobacterial
strains was partly derived from T cells and led to activation of
macrophages, namely, those that were infected. Concomitant with the
development of the infection with the virulent strain of M. avium there was an extensive depletion of lymphocytes in the
spleen. Thymectomy alone promoted the proliferation of the virulent,
but not of the less virulent, strain of M. avium. Our data
indicate that virulent strains of M. avium resist the antimicrobial mechanisms of IFN-
-activated macrophages and raise the
possibility that a second, T-cell-dependent signal is required for the
effective control of mycobacterial replication inside macrophages.
 |
INTRODUCTION |
Mycobacterium avium
infections are mostly found in immunocompromised human patients, such
as patients with AIDS who have low CD4+ T-cell counts
(16). M. avium infections are also found in human patients free of human immunodeficiency virus infection (23) or in veterinary contexts (32). This species can be isolated from environmental sources, and it is believed that environmental contact underlies the infection of human beings (31). The
ability of different isolates to grow in target organs of
experimentally infected animals such as mice can give us information
regarding the relative virulence among the clinical and environmental
isolates (21). Such studies have revealed an extraordinary
variation in the virulence of different strains. Also, it has long been known that phenotypic variation, apparent as the emergence of morphologically different colonies of mycobacteria growing on solid
media, is related to dramatic changes in the ability of a particular
strain of M. avium to grow and infect the host
(21). The molecular basis of virulence in M. avium is still not determined, nor do we understand the
relationship between virulence (as a microbial quality) and the host
response, namely, the immune response. We therefore compared two
strains of M. avium with distinct virulence properties: one
strain (strain 2447) can grow for a limited period of time, but its
growth is arrested by the emergence of a series of responses from both
the innate and the adaptive mechanisms of immunity; on the other hand,
strain 25291 proliferates extensively and eventually kills the infected
mouse. The ability of the latter strain to proliferate could be due to
its capacity either to downmodulate the immune response of the host or,
alternatively, to resist the antimicrobial mechanisms induced. It is
widely accepted that resistance to mycobacteria requires the secretion
of gamma interferon (IFN-
), which, by activating the mononuclear
phagocytes, leads to the control of the infection (1, 9, 13, 14,
27). We describe here the ability of the highly virulent strain
of M. avium to induce an immune response characterized by
high levels of secretion of IFN-
but to resist the antimicrobial
activity of the IFN-
-activated macrophages. Concomitant with the
progression of the infection, there is an extensive loss of the
lymphoid population, which may suggest that a second signal, associated
with the T cells, is lost, accounting for the susceptibility to infection.
 |
MATERIALS AND METHODS |
Reagents and antibodies.
Bacterial culture media were
purchased from Difco (Detroit, Mich.). Tween 80, oleic acid, bovine
serum albumin, phorbol myristate acetate (PMA), Triton X-100,
cytochrome c, and Escherichia coli lipopolysaccharide (LPS) were purchased from Sigma (St. Louis, Mo.).
Dulbecco's modified Eagle tissue culture medium, HEPES buffer, Hank's
balanced salt solution, fetal calf serum (FCS), and protein G columns
were purchased from Gibco Life Technologies (Paisley, Scotland). The
hybridomas GK1.5 (secreting anti-CD4 immunoglobulin G2a [IgG2a];
American Type Culture Collection [ATCC], Manassas, Va.), R4-6A2
(secreting anti-IFN-
IgG1 [ATCC]), and AN18 (secreting anti-IFN-
IgG1; DNAX, Palo Alto, Calif.) were grown in ascites fluid
in Harlan Sprague-Dawley nude mice to produce the monoclonal antibodies. All of the antibodies were purified by protein G-agarose affinity chromatography followed by dialysis against phosphate-buffered saline (PBS) before being used. Fluorescein isothiocyanate-conjugated rat anti-mouse CD4, phycoerythrin (PE)-conjugated rat anti-mouse CD8,
and PE-conjugated rat anti-mouse CD3 were purchased from Pharmingen,
San Diego, Calif.
Mice.
Specific-pathogen-free C57BL/6 and BALB/c female mice
were purchased from Gulbenkian Institute of Science, Oeiras, Portugal. Female C.B17 mice with severe combined immunodeficiency (SCID) were
purchased from Bommice (Ry, Denmark) and were screened for leakiness by
confirming the lack of serum immunoglobulin. Mice with the IFN-
gene
disrupted (IFN-
/
) were bred at our facilities in
HEPA filter-bearing cages from breeding pairs obtained from D. Dalton
(10). Outbred Harlan Sprague-Dawley nude mice were purchased
from the Gulbenkian Institute of Science. The animals were kept under
sterilized conditions, in HEPA filter-bearing cages, fed autoclaved
commercial chow, and given autoclaved drinking water ad libitum. The
animals were used at 5 to 12 weeks of age.
Bacteria.
M. avium strains 2447 (an AIDS isolate
obtained from F. Portaels, Institute of Tropical Medicine, Antwerp,
Belgium) and ATCC 25291 (an animal isolate), both growing as smooth
transparent colonies, were grown until mid-log phase in Middlebrook 7H9
medium plus 0.04% Tween 80 at 37°C. The bacteria were harvested by
centrifugation, suspended in a small volume of saline, and sonicated
with a Branson (Danbury, Conn.) sonifier for 15 s at 50 W to
disrupt bacterial clumps. This suspension was then diluted, frozen in
aliquots, and kept at
70°C until use. Before inoculation, bacterial
aliquots were thawed at 37°C and diluted in saline to the desired concentration.
In vivo infections.
The mice were infected intravenously
with 106 CFU of M. avium through the lateral
tail vein. Infected mice were sacrificed at different time points of
infection, and the organs were aseptically collected and homogenized in
a 0.04% Tween 80 solution in distilled water. The number of CFU of
M. avium in the livers, spleens, and lungs of the infected
mice was determined by serial dilution and plating the tissue
homogenates into 7H10 agar medium supplemented with oleic
acid-albumin-dextrose-catalase (OADC). In some cases, the mice were
thymectomized 3 weeks prior to infection. The depletion of
CD4+ T cells was achieved by the intraperitoneal
administration to the thymectomized mice of 0.2 mg of anti-CD4
monoclonal antibody (GK1.5) per animal, 3 days and 1 day before
infection and every 10 days during the course of infection.
Detection of immunoreactive IFN-
.
Blood was collected
from infected mice at different time points of infection and incubated
for 30 min at 37°C followed by incubation at 4°C to allow clot
formation and retraction. After centrifugation, serum was collected and
frozen at
70°C. The spleen homogenates were incubated with 1%
Triton X-100 for 2 h at 4°C. After centrifugation, the
supernatants were collected and frozen at
70°C. Quantification of
IFN-
in the serum and spleen homogenates was done by enzyme-linked
immunosorbent assay with the IFN-
-specific monoclonal antibodies
R4-6A2 as the coating antibody and biotin-conjugated AN18 as the
secondary antibody.
Semiquantitative RT-PCR.
Total mRNA from portions of the
spleens, livers, and lungs of infected mice was obtained by using
guanidinium thiocyanate-phenol-chloroform purification and stored at
70°C until processed further. Reverse transcription (RT) was
performed with p(dT)12-18 oligonucleotides (Pharmacia Biotech, Uppsala,
Sweden) and Superscript reverse transcriptase (Gibco Life Technologies)
in the presence of 10 U of RNase inhibitor (Promega, Madison, Wis.).
cDNA was amplified with Taq polymerase (Oncor Appligene,
Gaithersburg, Md.) in the presence of a specific pair of primers for
the housekeeping gene coding for hypoxanthine phosphoribosyl
transferase (HPRT) or for IFN-
(sequences are described in reference
19) in a Gene Amp PCR System 9600 (Perkin-Elmer) for
30 cycles. The amplification products were generated under conditions
of linear correlation with the amount of cDNA and standardized for
similar HPRT mRNA. The amplification products were run in parallel with
a titration of both HPRT and IFN-
cDNA from internal standards in a
1.4% agarose gel, transferred to a nitrocellulose membrane (Hybond N+;
Amersham, Buckinghamshire, United Kingdom), and hybridized with
specific [
-32P]deoxyCTP-labeled probes. The membranes
were exposed, and the photographic plates were read with the aid of a
computer-assisted scanner. The values of the amplified product for
IFN-
were corrected for the amount of HPRT in each sample, taking
into account the titration of both HPRT and IFN-
cDNA. All samples
from the same time points of infection were run and blotted in parallel
with the titrations and exposed to the same photographic plates to ensure a correct comparison of the signals generated.
Analysis of the state of activation of peritoneal
macrophages.
Peritoneal cells were obtained from mice at different
time points of infection by washing the peritoneal cavities of the
infected mice with PBS. The cells were washed, resuspended in
Dulbecco's modified Eagle medium containing 10 mM HEPES buffer and
supplemented with 10% FCS, and cultured in triplicate at a density of
3 × 106 per well in a 24-well tissue culture plate.
After a 2-h incubation at 37°C in a 7% CO2 atmosphere,
nonadherent cells were removed by extensive washing with prewarmed
Hank's balanced salt solution. Adherent cells were incubated for 3 days in the presence of 1 µg of E. coli LPS/ml for the
detection of nitrite secretion or incubated for 90 min at 37°C in a
7% CO2 atmosphere with a cytochrome c solution
for the detection of superoxide secretion as described elsewhere
(4). The concentration of NO2
in
the supernatants was measured with the Griess reagent as described elsewhere (4). Cell monolayers were lysed by three cycles of freezing and thawing, and the amount of protein in each well was determined by the Lowry method.
Immunohistochemistry.
Liver biopsy samples were fixed in
formaldehyde and embedded in paraffin. Sections were deparaffinated and
placed in 10 mM sodium citrate buffer (pH 6.0) followed by pressure
cooking for exactly 1 min. For pressure cooker pretreatment, a normal
household pressure cooker was filled with enough 10 mM sodium citrate
buffer to cover the slides. The buffer was brought to a boil before the slides were submerged. The lid was closed and the sections were boiled
at top pressure for exactly 1 min. The tissue sections were then
covered with carbol fuchsin (Merck, Darmstadt, Germany) and heated
until they were steaming. After they had cooled for 5 min, a solution
containing 70% ethanol and 0.5% hydrochloric acid was applied for
differentiation, followed by thorough rinsing. After being blocked for
20 min in 1% H2O2, the slides were stained for
acid-fast bacteria and then with a rabbit anti-mouse inducible nitric
oxide synthase (iNOS) (Genzyme-Virotech, Russelsheim, Germany) in
Tris-buffered saline with 10% FCS for 30 min in a humid chamber. As a
bridging antibody, appropriately diluted goat anti-rabbit IgG-peroxidase (Dianova, Hamburg, Germany) was used, and as a tertiary
antibody, diluted rabbit anti-goat IgG-peroxidase (Dianova) was used,
in sequential incubations of 30 min each.
Fluorescence-activated cell sorter analysis.
Single-cell
suspensions from spleens of control and infected mice were prepared by
teasing portions of the spleen through a fine-mesh screen in PBS
containing 3% FCS. Erythrocytes were lysed by incubation of the cell
suspensions with hemolytic buffer (155 mM NH4Cl, 10 mM
KHCO3, pH 7.2) for 5 min at room temperature and thoroughly
washed. For immunofluorescence staining, 106 cells were
incubated in a microtiter plate with fluorescein
isothiocyanate-conjugated anti-CD4 antibody (dilution, 1:100) and
PE-conjugated anti-CD8 antibody (dilution, 1:100) or with PE-conjugated
anti-CD3 antibody (dilution, 1:50). The cells were washed twice with
PBS-3% FCS, and propidium iodide was added to the cells at a final
concentration of 1 µg/ml to allow the exclusion of dead cells. The
analysis of the cell populations was based on the acquisition of 10,000 events in a Becton Dickinson FACSort equipped with PCLysis II software.
Statistical analysis.
Student's t test was used
to compare data.
 |
RESULTS |
In Fig. 1A we present the
proliferation of the two isolates of M. avium in the organs
of intravenously infected C57Bl/6 mice. The animals were inoculated
with similar infectious doses of either strain 2447 or strain 25291. Whereas the growth of the former was slow, in part due to
IFN-
-induced antimycobacterial mechanisms (1), strain
25291 proliferated extensively with no sign of any restriction by the
host. To confirm the role of IFN-
in the restriction of growth of
strain 2447 and to know whether this cytokine could still be involved
in some degree of control of the more virulent 25291 strain, we
infected mice with the IFN-
gene disrupted, as well as the
respective controls, which were heterozygous animals with similar
genetic background, i.e., BALB/c. As shown in Fig. 1B,
IFN-
-deficient mice allowed an enhanced proliferation of strain 2447 compared to the respective controls, confirming previous findings in
studies with neutralizing antibodies (1). Despite the
absence of IFN-
, the knockout animals evidenced the ability to
restrict mycobacterial proliferation late in infection, especially in
their livers and spleens. No differences in proliferation of strain
25291 were observed in the spleens of IFN-
-deficient mice compared
with their controls (Fig. 1C). Increased mycobacterial proliferation
was observed in the lungs of the knockout animals compared to the
control heterozygotes during the latter infection as well as later in
infection, in the liver, suggesting that IFN-
was being produced, at
least in the lungs of control mice infected with the virulent strain of
M. avium. The lack of an exacerbation of mycobacterial
growth observed in the spleens and livers following disruption of the
IFN-
gene could be due to a lack of production of this cytokine
during infection of the wild-type animals by the virulent strain.
Therefore, we analyzed IFN-
production during infection of C57Bl/6
mice by either of the two strains of M. avium. As shown in
Fig. 2A, high levels of immunoreactive
IFN-
were detectable in the sera of the mice infected with the
highly virulent strain of M. avium. In fact, the levels of
the cytokine were even higher than the ones found in mice infected with
the low-virulence strain. Similar results were obtained when the
presence of immunoreactive IFN-
was analyzed in spleen homogenates
(Fig. 2B), showing that the highly virulent strain of M. avium was able to induce a prominent IFN-
response in one of
the target organs although it was unable to induce the restriction of
mycobacterial proliferation. The kinetics of IFN-
production was
also evaluated by performing RT-PCR analysis on samples taken from all
the organs studied. As shown in Fig. 2C, expression of IFN-
was
found throughout the course of both infections. Densitometric analysis
revealed that the expression of this cytokine on day 15 was, on the
whole, higher in the organs of the mice infected with strain 25291 than in those of mice infected with the less virulent strain 2447 (Fig. 2C).
This situation was reversed by day 30 of infection, the time point of
peak expression of IFN-
, when similar levels of expression were
observed in the spleen and the liver and an opposite relationship was
observed in the lungs. A similar study showed that levels of another
cytokine, tumor necrosis factor alpha (TNF-
) correlated well with
the levels of IFN-
(data not shown). The levels of immunoreactive
IFN-
detected in the serum at days 15 and 30 correlated with the
levels of expression of this cytokine in the liver
(r2 = 0.69).

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 1.
Proliferation of two M. avium strains in the
organs of C57Bl/6 mice (A) or IFN- / mice and their
heterozygous controls (B and C). (A) C57Bl/6 mice were infected with
similar inoculum doses of strain 25291 (circles) or of strain 2447 (squares), and viable counts were done at the indicated time points in
the spleens, livers, and lungs. (B and C) IFN- /
(solid symbols) and (IFN- / × BALB/c)F1 (open
symbols) mice were infected with strains 2447 (B) or 25291 (C), and
viable counts were done in the same organs as for panel A at the
indicated time points. Statistically different values are indicated by
* for P < 0.01 and ** for P < 0.05. Each time point represents the geometric mean of CFU values
from four mice ± 1 standard deviation.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 2.
Amounts of immunoreactive IFN- in the sera (A) and
spleen homogenates (B) of C57Bl/6 mice infected at the indicated time
points with M. avium strains 2447 (open squares) or 25291 (solid circles). Each point represents the determination of IFN-
from one animal. (C) Analysis by RT-PCR of IFN- gene expression in
the spleens, livers, and lungs of C57Bl/6 mice infected with M. avium strains 2447 or 25291 at days 15 and 30 of infection and of
uninfected control mice. Southern blotting of the PCR products for HPRT
and IFN- was performed with 32P-labeled probes, and the
photographic plates were scanned and analyzed. The data are presented
as the means ± 1 standard deviation of the corrected results
(standardized for the HPRT message) in terms of the intensity of the
reading in pixels. The open bars represent the signal for uninfected
mice, the hatched bars represent those of strain 2447-infected mice,
and the solid bars represent those of strain 25291-infected mice.
Independent analysis of the results for days 15 and 30 was done, and
therefore, exposure of the photographic plates differed between those
time points, leading to different readings of the uninfected material.
ND, not detected. Note that linear increases in intensity (in pixels)
correspond to exponential increases in PCR product under the conditions
used here. Statistically significant differences according to
Student's t test are labeled * (P < 0.05) or ** (P < 0.01).
|
|
One straightforward explanation for the ineffectiveness of IFN-
in
inducing stasis of M. avium 25291 would be a failure of the
cytokine to activate macrophages. We therefore isolated peritoneal macrophages from the infected mice to look at the role of the IFN-
produced during infection in modulating macrophage functions. Since
both the induction of iNOS and the priming of the respiratory burst
enzymes are mostly dependent on IFN-
, we measured the ability of the
isolated macrophages to secrete nitrite or superoxide in response to
LPS or PMA as their respective agonistic triggers. Macrophage
activation, as evaluated by the two chosen markers, was found to occur
among peritoneal cells of mice infected with either of the two
mycobacterial strains (Fig. 3). The
degree of activation was higher in macrophages from mice infected with
the M. avium strain with the higher virulence than in the
macrophages isolated from the animals infected with the low-virulence
strain. Therefore, IFN-
produced during the response to infection
was acting on target macrophages, leading to their activation in a dose-response-related manner. A trivial explanation for the inability of IFN-
to control the growth of strain 25291 could be that the infected macrophages (a minority of the macrophages isolated from these
mice and studied in vitro) were themselves unresponsive to the cytokine
and therefore not undergoing the activation pathways. In such a
scenario, the overall activation of the macrophage population as a
whole would mask a potential unresponsiveness of a small subpopulation,
albeit the most important one for the control of the infection. To be
able to study macrophage activation on a single-cell basis, we chose to
detect iNOS protein by immunohistochemistry. At the same time,
acid-fast bacteria were visualized in the same tissues to assess the
colocalization of iNOS and the mycobacteria. As shown in Fig.
4, iNOS expression in the livers of
infected mice was induced by infection with either strain of M. avium and was more marked in the organs of the animals infected
with the highly virulent strain than in those from mice infected with
the low-virulence strain. Such upregulation of iNOS was observed in the
infected as well as the apparently noninfected macrophages in the
granuloma with no obvious differences in intensity of staining. Although the data are presented for BALB/c mice, similar results were
obtained with C57Bl/6 animals. It can also be seen from Fig. 4 that
granuloma formation, as well as activation (at least for iNOS), is
severely reduced in the absence of endogenous IFN-
, as judged from
the lesions in mice with the IFN-
gene disrupted.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 3.
Kinetic analysis of macrophage activation. Peritoneal
cells from infected animals were collected at different time points of
infection, cultured, and used to assess their ability to secrete
nitrite in response to LPS (A) or superoxide in response to PMA (B).
The open symbols represent the results from mice infected with strain
2447, and the closed symbols represent those from mice infected with
strain 25291. Each value represents the mean ± 1 standard
deviation of triplicates from a pool of cells from four mice. *,
P < 0.05; **, P < 0.01.
|
|

View larger version (155K):
[in this window]
[in a new window]
|
FIG. 4.
Immunohistological evidence of macrophage activation in
hepatic granulomas. (A) Liver sections were stained simultaneously with
a polyclonal antibody for the expression of iNOS, with reactivity
revealed through a peroxidase-conjugated secondary antibody, and for
the presence of acid-fast bacilli. Sections from mice with the iNOS
gene disrupted that were infected for 2 months with M. avium
25291 were used as a negative control for specificity (magnification,
×600) (B and C) Extensively labeled granulomas were observed in BALB/c
mice infected for 1 month with strain 2447 (B) (magnification, ×1,200)
or strain 25291 (C) (magnification, ×1,200). (D) Note the presence of
acid-fast bacilli in the granuloma induced by strain 25291 (magnification, ×2,400) despite the marked reaction for iNOS. (E and
F) IFN- gene-deficient mice on a BALB/c background infected with
strain 2447 (E) (magnification, ×1,700) or strain 25291 (F)
(magnification, ×1,700) showed reduced granuloma formation as
well as reduced reactivity for iNOS. Note the extensive proliferation
of strain 25291 inside macrophages of IFN- / mice in
panel F.
|
|
The lack of control of the proliferation of strain 25291 even in the
presence of high levels of IFN-
could suggest a complete resistance
of this strain to the antimycobacterial mechanisms induced by this
cytokine. However, we have been able to induce some restriction of
proliferation of this strain in vitro by activating macrophages with
IFN-
(3). Also, data from Fig. 1 suggest that IFN-
can
induce some growth restriction of strain 25291 in the lung. Thus, an
alternative explanation is that for in vivo control of M. avium proliferation there is a need for a second signal in
addition to that provided by IFN-
and possibly also by TNF-
. That
second signal would be dependent on T cells, as the control of growth
of strain 2447 is lost upon in vivo depletion of CD4+ T
cells (1). To assess this hypothesis, we followed the number of T cells in the spleen during the course of infection by either of
the strains of M. avium. As shown in Fig.
5, T cells expanded during infection with
strain 2447, peaking at day 30 of infection. This increase in T cells
was mostly due to CD4+ T cells, although some expansion of
CD8+ T cells could also be found. In contrast, the number
of T cells of both subsets failed to increase in response to infection
by the virulent strain 25291. In the latter infection, T cells sharply decreased in number after day 30 of infection.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 5.
Kinetics of the effect of infection on numbers of
CD4+ and CD8+ cells in the spleens of mice
infected with strains 2447 (open symbols) or 25291 (solid symbols).
|
|
On prolonged observation of mice infected with strain 25291, thymic
atrophy was found. Therefore, we analyzed the populations in the thymus
of mice infected for 1 or 60 days with either strain of M. avium. As shown in Fig. 6A,
infection by strain 25291 (but not by strain 2447) induced a decrease
in the numbers of all subsets of thymic T cells. This phenomenon was
not studied here in terms of mechanisms, but we speculated whether it
could represent an attempt by the host to replenish the T-cell
populations of the peripheral organs infected with strain 25291. We
therefore compared the effects of thymectomy on resistance to either
strain 2447 or strain 25291. As shown in Fig. 6B, thymectomy on its own
did not affect the number of viable mycobacteria in the organs of mice
infected with the less virulent strain, whereas the use of depleting
anti-CD4 monoclonal antibodies increased mycobacterial proliferation.
In contrast, mice that were only thymectomized became more susceptible
to strain 25291 to an extent similar to that of CD4-depleted animals.

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 6.
Involvement of the thymus in systemic infection by
M. avium 2447 or 25291. (A) Cellularity of the thymus in
terms of numbers of CD4+ CD8 (open bars),
CD4 CD8+ (solid bars), CD4+
CD8+ (hatched bars), or total cells (shaded bars) of the
thymi of mice infected for 1 or 60 days with strains 2447 (left) or
25291 (right). Results are means ± 1 standard deviation (SD). (B)
Effects of thymectomy alone (shaded bars) or thymectomy followed by
CD4+-T-cell depletion (solid bars) on the proliferation of
M. avium 2447 (left) or 25291 (right) compared to that in
untreated mice (open bars) at 40 days of infection. The results are
shown as means ± 1 SD (n = 5). (C) Infection of
SCID mice with M. avium 25291. The growth of M. avium was evaluated in the spleens, livers, and lungs of BALB/c
and SCID mice after 30 days of infection. The results are shown as the
geometric means ± 1 SD of the CFU values from three or four mice.
The degree of macrophage activation of the peritoneal cells from the
same animals as evaluated from the production of LPS-stimulated nitrite
secretion is shown on the right. In vitro production of
NO2 by peritoneal macrophages from uninfected
BALB/c mice (open bar), infected BALB/c mice (hatched bar), or infected
SCID mice (solid bar) is shown. The data represent means ± 1 SD
of triplicates from a pool of three or four mice. *, P < 0.05; **, P < 0.01.
|
|
The data presented so far would argue that during infection by the most
virulent strain of M. avium, there was a T-cell response leading to secretion of IFN-
, but as the mycobacteria resisted the
mechanisms induced in macrophages by the cytokine, a progressive loss
of T cells took place, causing the lack of the required putative second
signal. One could argue that the IFN-
response to strain 25291, unlike that to strain 2447, which is dependent on T cells (1,
2), could rely on T-cell-independent mechanisms. We therefore
infected SCID and BALB/c mice with strain 25291 and studied
mycobacterial growth as well as macrophage activation. As shown in Fig.
6C, the highly virulent strain proliferated to similar numbers in both
mouse strains, confirming previous findings (1). However, in
the absence of T cells, macrophage activation in SCID mice was
significantly lower than that in control BALB/c animals (Fig. 6C).
 |
DISCUSSION |
For mycobacteria in general and M. avium in particular
it is believed that IFN-
mediates resistance to infection through its ability to activate the macrophage's antimycobacterial machinery. The ability of different isolates or strains of M. avium to
proliferate in mice varies extensively, ranging from those that are
efficiently eliminated to those that grow progressively and eventually
kill the animal (21). Such virulence properties in M. avium have not yet been studied in detail. Here we have analyzed
the relationship of virulence to the induction of immune responses. In
general terms, the inability of the host to control the proliferation of a strain of M. avium with high virulence could be due to
either a downmodulation of the IFN-
response or resistance to the
antimycobacterial mechanisms induced by the cytokine. We found that the
infection of mice with a highly virulent strain of M. avium
was associated with the in vivo induction of IFN-
in the infected
host. Such production of the cytokine was accompanied by macrophage
activation, as evaluated by the priming of the oxidative response and
NO synthesis. Furthermore, macrophage activation took place in those
macrophages that were infected, showing that the virulent mycobacteria
were not turning down the activation pathways of the infected
macrophages. The IFN-
response was dependent, at least to a great
extent, on the induction of T cells, as SCID mice exhibited lower
levels of macrophage activation. The production of IFN-
in response to infection by the virulent strain was similar to or even greater than
that found during infection by a strain of lower virulence whose growth
came under control by mechanisms at least partly dependent on IFN-
.
Therefore, it appears that virulent mycobacteria survive in the host
not by turning down the IFN-
response but rather by adopting
strategies to survive within activated macrophages. Data from Fig. 1
show that virulent mycobacteria resist IFN-
-mediated mechanisms in
vivo better than less virulent strains but also that, in the absence of
IFN-
, virulent M. avium already is endowed with a greater
proliferation potential.
The in vivo data presented here contrast somewhat with our previous
findings in in vitro macrophage cultures, where some bacteriostasis of
strain 25291 could be induced in bone marrow-derived macrophages activated by IFN-
with or without TNF-
(1, 3).
Furthermore, the degree of growth restriction observed in vitro with
IFN-
-activated macrophages is always smaller than the restriction
found in vivo with strain 2447 (our unpublished observations). Also,
when resident peritoneal macrophages are used, there is very limited
ability to induce bacteriostasis of M. avium, even strain
2447 (our unpublished observations). Together with the fact that
IFN-
can lead to a small but significant reduction in proliferation
of strain 25291 in the lung (Fig. 1C), we find very likely the
possibility that additional activating signals exist in vivo to lead to
complete bacteriostasis of M. avium. These signals would
require T cells, as T-cell depletion abrogates the control of the
proliferation of strain 2447 (1). This assumption is
supported by the fact that IFN-
-deficient mice could start
controlling the proliferation of strain 2447 in their spleens and
livers at some point in the infection (Fig. 1B). The virulence of
strain 25291 would therefore involve an enhanced resistance to the
limited bacteriostatic effects of IFN-
coupled with a concomitant
downmodulation of the putative second signal provided by T cells. In
line with these speculations, we found that those virulent strains,
while able to resist the mechanisms induced on the macrophage by
IFN-
, caused a dramatic loss of T cells after having led to
macrophage activation through IFN-
secretion. This loss would
therefore help the survival of the microbe by abolishing the second
signal postulated above. Other groups have indeed found that T cells
are required for the optimal induction of mycobacterial growth arrest
or killing (7, 28, 29). Also, this hypothesis would explain
why many groups failed to show any induction of antimycobacterial
activity by IFN-
in vitro, especially with human monocytes and
macrophages (6, 12, 24, 26, 30), despite the very convincing
literature describing the importance of IFN-
in vivo in both mice
and human beings (9, 14, 17, 18, 20, 22). Hanano and
colleagues (15) have recently described an experimental
model of Pneumocystis carinii infection where the pathogen
can be controlled in the absence of IFN-
or TNF-
signalling but
not when T cells, particularly from the CD4+ subset, are
nonfunctional. Curiously, the lack of control of P. carinii
in the latter situation happened when evident macrophage activation is
taking place. These data suggest that T-cell-dependent but IFN-
-
and TNF-
-independent resistance mechanisms exist. Whether unknown
macrophage activation pathways are associated with those mechanisms
cannot be answered at present. In the case of the strains of M. avium used here, we can exclude TNF-
as the second signal, as
this cytokine is as efficiently induced by the virulent strain as by
the low-virulence strain and, more important, the lack of the p55
receptor in mice with disrupted genes did not affect the course of the
mycobacterial proliferation of either strain (our unpublished data).
The mechanism(s) leading to the demise of the T cells is still unclear.
However, one could speculate, as was already done several years ago by
Collins (8), that a subclinical M. avium infection in human beings in the initial phase of human
immunodeficiency virus infection could be an accessory factor in the
development of immunodeficiency by triggering macrophage activation and
the subsequent elimination of locally recruited CD4+ T cells.
The molecular mechanisms responsible for the expression of
mycobacteriostasis in M. avium-infected macrophages are
still not known. It is clear that reactive oxygen species play a very
limited role in restriction of growth of a very few isolates of
M. avium, mostly those that trigger the secretion of high
amounts of TNF-
by the infected macrophage and that show a limited
ability to proliferate inside those cells both in vivo and in vitro
(25). Also, activation of the infected macrophages with
IFN-
and other cytokines induces an enhanced antimycobacterial
activity on those cells, which is independent of the generation of
reactive oxygen species (3). Nitric oxide and related
antimicrobial molecules are also not involved in the restriction of the
growth of M. avium inside activated macrophages (3, 5,
11, 33). Here we have evaluated the degree of macrophage
activation by measuring the production of either of the reactive
species. This analysis was done to test whether IFN-
had exerted its
effects on the macrophage and not to evaluate antimycobacterial
mechanisms. As we do not know what macrophage functions restrict the
growth of M. avium, we could not evaluate such functions
here in either type of infection.
In summary, we showed that virulent strains of M. avium
stimulate IFN-
production in vivo, namely, through activation of T
cells. The reason for their resistance to these effector mechanisms is
not clear, but we speculate that such strains downmodulate a second,
T-cell-derived signal by promoting T-cell death, namely, through nitric
oxide-mediated pathways. Therefore, despite the activation of
macrophage functions, such as free radical production, virulent strains
would escape control by still-unidentified effector mechanisms of the
macrophage. These data stress the need to identify new correlates of
protective immunity in mycobacteriosis.
 |
ACKNOWLEDGMENTS |
This work was partially supported by contracts AI-41922 from the
NIH and P/SAU 58/96 from the PRAXIS XXI program (Lisbon). M.F. and
A.S.G. are recipients of fellowships from the PRAXIS XXI program.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratory of
Microbiology and Immunology of Infection, Institute for Molecular and Cell Biology, Rua do Campo Alegre 823, 4150 Porto, Portugal. Phone: 351.2.6074952. Fax: 351.2.6099157. E-mail:
rappelb{at}ibmc.up.pt.
Editor:
E. I. Tuomanen
 |
REFERENCES |
| 1.
|
Appelberg, R.,
A. G. Castro,
J. Pedrosa,
R. A. Silva,
I. M. Orme, and P. Minóprio.
1994.
The role of gamma interferon and tumor necrosis factor alpha during the T-cell-independent and -dependent phases of Mycobacterium avium infection.
Infect. Immun.
62:3962-3971[Abstract/Free Full Text].
|
| 2.
|
Appelberg, R., and J. Pedrosa.
1992.
Induction and expression of protective T cells during Mycobacterium avium infections in mice.
Clin. Exp. Immunol.
87:379-385[Medline].
|
| 3.
|
Appelberg, R., and I. M. Orme.
1993.
Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages.
Immunology
80:352-359[Medline].
|
| 4.
|
Appelberg, R.,
I. M. Orme,
M. I. P. Sousa, and M. T. Silva.
1992.
In vitro effects of interleukin-4 on interferon- -induced macrophage activation.
Immunology
76:553-559[Medline].
|
| 5.
|
Bermudez, L. E.
1993.
Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide.
Clin. Exp. Immunol.
91:277-281[Medline].
|
| 6.
|
Blanchard, D. K.,
M. B. Michelini-Norris, and J. Y. Djeu.
1991.
Interferon decreases the growth inhibition of Mycobacterium avium-intracellulare complex by fresh human monocytes but not by culture-derived macrophages.
J. Infect. Dis.
164:152-157[Medline].
|
| 7.
|
Bonecini-Almeida, M. G.,
S. Chitale,
I. Boutsikakis,
J. Geng,
H. Doo,
S. He, and J. L. Ho.
1998.
Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN- and primed lymphocytes.
J. Immunol.
160:4490-4499[Abstract/Free Full Text].
|
| 8.
|
Collins, F. M.
1986.
Mycobacterium avium-complex infections and development of the acquired immunodeficiency syndrome: casual opportunist or causal cofactor?
Int. J. Lepr. Other Mycobact. Dis.
54:458-474[Medline].
|
| 9.
|
Cooper, A. M.,
D. K. Dalton,
T. A. Stewart,
J. P. Griffin,
D. G. Russell, and I. M. Orme.
1993.
Disseminated tuberculosis in interferon gene-disrupted mice.
J. Exp. Med.
178:2243-2247[Abstract/Free Full Text].
|
| 10.
|
Dalton, D. K.,
S. Pitts-Meek,
S. Keshav,
I. S. Figari,
A. Bradley, and T. A. Stewart.
1993.
Multiple defects of immune cell function in mice with disrupted interferon- genes.
Science
259:1739-1742[Abstract/Free Full Text].
|
| 11.
|
Doi, T.,
M. Ando,
T. Akaike,
M. Suga,
K. Sato, and H. Maeda.
1993.
Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis.
Infect. Immun.
61:1980-1989[Abstract/Free Full Text].
|
| 12.
|
Douvas, G. S.,
D. L. Looker,
A. E. Vatter, and A. J. Crowle.
1985.
Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria.
Infect. Immun.
50:1-8[Abstract/Free Full Text].
|
| 13.
|
Flórido, M.,
R. Appelberg,
I. M. Orme, and A. M. Cooper.
1997.
Evidence for a reduced chemokine response in the lungs of beige mice infected with Mycobacterium avium.
Immunology
95:600-606.
|
| 14.
|
Flynn, J. L.,
J. Chan,
K. J. Triebold,
D. K. Dalton,
T. A. Stewart, and B. R. Bloom.
1993.
An essential role for interferon in resistance to Mycobacterium tuberculosis infection.
J. Exp. Med.
178:2249-2254[Abstract/Free Full Text].
|
| 15.
|
Hanano, R.,
K. Reifenberg, and S. H. E. Kaufmann.
1998.
Activated pulmonary macrophages are insufficient for resistance against Pneumocystis carinii.
Infect. Immun.
66:305-314[Abstract/Free Full Text].
|
| 16.
|
Horsburgh, C. R., Jr.
1991.
Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.
N. Engl. J. Med.
324:1332-1338[Medline].
|
| 17.
|
Jouanguy, E.,
F. Altare,
S. Lamhamedi,
P. Revy,
J.-F. Emile,
M. Newport,
M. Levin,
S. Blanche,
E. Seboun,
A. Fischer, and J.-L. Casanova.
1996.
Interferon- -receptor deficiency in an infant with fatal Bacille Calmette-Guérin infection.
N. Engl. J. Med.
335:1956-1961[Free Full Text].
|
| 18.
|
Jouanguy, E.,
S. Lamhamedi-Cherradi,
F. Altare,
M.-C. Fondanèche,
D. Tuerlinckx,
S. Blanche,
J.-F. Emile,
J.-L. Gaillard,
R. Schreiber,
M. Levin,
A. Fischer,
C. Hivroz, and J.-L. Casanova.
1997.
Partial interferon- receptor 1 deficiency in a child with tuberculoid Bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis.
J. Clin. Investig.
100:2658-2664[Medline].
|
| 19.
|
Murphy, E.,
S. Hieny,
A. Sher, and A. O'Garra.
1993.
Detection of in vivo expression of interleukin-10 using a semi-quantitative polymerase chain reaction method in Schistosoma mansoni infected mice.
J. Immunol. Methods
162:211-223[Medline].
|
| 20.
|
Newport, M. J.,
C. M. Huxley,
S. Huston,
C. M. Hawrylowicz,
B. A. Oostra,
R. Williamson, and M. Levin.
1996.
A mutation in the interferon- -receptor gene and susceptibility to mycobacterial infection.
N. Engl. J. Med.
335:1941-1949[Abstract/Free Full Text].
|
| 21.
|
Pedrosa, J.,
M. Flórido,
Z. M. Kunze,
A. G. Castro,
F. Portaels,
J. J. McFadden,
M. T. Silva, and R. Appelberg.
1994.
Characterization of the virulence of Mycobacterium avium complex isolates in mice.
Clin. Exp. Immunol.
98:210-216[Medline].
|
| 22.
|
Pierre-Audigier, C.,
E. Jouanguy,
S. Lamhamedi,
F. Altare,
J. Rauzier,
V. Vincent,
D. Canioni,
J.-F. Emile,
A. Fischer,
S. Blanche,
J.-L. Gaillard, and J.-L. Casanova.
1997.
Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon receptor deficiency.
Clin. Infect. Dis.
24:982-984[Medline].
|
| 23.
|
Prince, D. S.,
D. D. Peterson,
R. M. Steiner,
J. E. Gottlieb,
R. Scott,
H. L. Israel,
W. G. Figueroa, and J. E. Fish.
1989.
Infection with Mycobacterium avium complex in patients without predisposing conditions.
N. Engl. J. Med.
321:863-866[Abstract].
|
| 24.
|
Rook, G. A. W.,
J. Steele,
M. Ainsworth, and B. R. Champion.
1986.
Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages.
Immunology
59:333-338[Medline].
|
| 25.
|
Sarmento, A. M., and R. Appelberg.
1996.
Involvement of reactive oxygen intermediates in the tumor necrosis factor-dependent bacteriostasis of Mycobacterium avium.
Infect. Immun.
64:3224-3230[Abstract].
|
| 26.
|
Shiratsuchi, H.,
J. L. Johnson,
H. Toba, and J. J. Ellner.
1990.
Strain- and donor-related differences in the interaction of Mycobacterium avium with human monocytes and its modulation by interferon- .
J. Infect. Dis.
162:932-938[Medline].
|
| 27.
|
Silva, R. A.,
T. F. Pais, and R. Appelberg.
1998.
Evaluation of IL-12 in immunotherapy and vaccine design in experimental Mycobacterium avium infections.
J. Immunol.
161:5578-5585[Abstract/Free Full Text].
|
| 28.
|
Silver, R. F.,
Q. Li,
W. H. Boom, and J. J. Ellner.
1998.
Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects.
J. Immunol.
160:2408-2417[Abstract/Free Full Text].
|
| 29.
|
Sypek, J. P.,
S. Jacobson,
A. Vorys, and D. J. Wyler.
1993.
Comparison of gamma interferon, tumor necrosis factor, and direct cell contact in activation of antimycobacterial defense in murine macrophages.
Infect. Immun.
61:3901-3906[Abstract/Free Full Text].
|
| 30.
|
Toba, H.,
J. T. Crawford, and J. J. Ellner.
1989.
Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage-activating factor activity of gamma interferon.
Infect. Immun.
57:239-244[Abstract/Free Full Text].
|
| 31.
|
von Reyn, C. F.,
J. N. Maslow,
T. W. Barber,
J. O. Falkinham III, and R. D. Arbeit.
1994.
Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS.
Lancet
343:1137-1141[Medline].
|
| 32.
|
Wolinsky, E.
1979.
Nontuberculous mycobacteria and associated diseases.
Am. Rev. Resp. Dis.
119:107-159[Medline].
|
| 33.
|
Zhao, B.,
M. T. Collins, and C. J. Czuprynski.
1997.
Effects of gamma interferon and nitric oxide on the interaction of Mycobacterium avium subsp. paratuberculosis with bovine monocytes.
Infect. Immun.
65:1761-1766[Abstract].
|
Infection and Immunity, July 1999, p. 3610-3618, Vol. 67, No. 7
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Florido, M., Pearl, J. E., Solache, A., Borges, M., Haynes, L., Cooper, A. M., Appelberg, R.
(2005). Gamma Interferon-Induced T-Cell Loss in Virulent Mycobacterium avium Infection. Infect. Immun.
73: 3577-3586
[Abstract]
[Full Text]
-
Pearl, J. E., Khader, S. A., Solache, A., Gilmartin, L., Ghilardi, N., deSauvage, F., Cooper, A. M.
(2004). IL-27 Signaling Compromises Control of Bacterial Growth in Mycobacteria-Infected Mice. J. Immunol.
173: 7490-7496
[Abstract]
[Full Text]
-
Florido, M., Borges, M., Yagita, H., Appelberg, R.
(2004). Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium. J. Leukoc. Biol.
76: 1039-1046
[Abstract]
[Full Text]
-
Feng, C. G., Collazo-Custodio, C. M., Eckhaus, M., Hieny, S., Belkaid, Y., Elkins, K., Jankovic, D., Taylor, G. A., Sher, A.
(2004). Mice Deficient in LRG-47 Display Increased Susceptibility to Mycobacterial Infection Associated with the Induction of Lymphopenia. J. Immunol.
172: 1163-1168
[Abstract]
[Full Text]
-
Mannering, S. I., Cheers, C.
(2002). Interleukin-2 and Loss of Immunity in Experimental Mycobacterium avium Infection. Infect. Immun.
70: 27-35
[Abstract]
[Full Text]
-
Ehlers, S., Richter, E.
(2000). Gamma Interferon Is Essential for Clearing Mycobacterium genavense Infection. Infect. Immun.
68: 3720-3723
[Abstract]
[Full Text]
-
Appelberg, R., Leal, I. S., Pais, T. F., Pedrosa, J., Florido, M.
(2000). Differences in Resistance of C57BL/6 and C57BL/10 Mice to Infection by Mycobacterium avium Are Independent of Gamma Interferon. Infect. Immun.
68: 19-23
[Abstract]
[Full Text]
-
Pais, T. F., Appelberg, R.
(2000). Macrophage Control of Mycobacterial Growth Induced by Picolinic Acid Is Dependent on Host Cell Apoptosis. J. Immunol.
164: 389-397
[Abstract]
[Full Text]